Squarepoint
SOPH icon

Squarepoint’s SOPHiA GENETICS SOPH Stock Holding History

Squarepoint’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,231
Closed -$48.7K – 4848
2025
Q3 		$48.7K Buy
+10,231
New +$35.2K ﹤0.01% 4231
2025
Q1 		– Sell
-13,753
Closed -$42.9K – 5352
2024
Q4 		$42.9K Sell
13,753
-5,886
-30% -$20K ﹤0.01% 4869
2024
Q3 		$71.4K Buy
+19,639
New +$79.8K ﹤0.01% 3940
2021
Q4 		– Sell
-23,969
Closed -$420K – 3496
2021
Q3 		$420K Buy
+23,969
New +$422K ﹤0.01% 2062

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Squarepoint's SOPH Position: Q4 2025 in Review

Squarepoint sold out of SOPHiA GENETICS (SOPH) in Q4 2025, closing a stake of 10,231 shares — an estimated $48.7K sold.

Squarepoint first reported a position in SOPH in Q3 2021 and held it in 4 quarters. The position peaked at $420K in Q3 2021. 42 funds tracked by Wall St. Rank hold SOPH as of Q4 2025.

  • Squarepoint reported no remaining SOPHiA GENETICS position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 10,231 SOPHiA GENETICS shares in Q4 2025, an estimated $48.7K.
  • Squarepoint first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 4 quarters.
  • Squarepoint's SOPHiA GENETICS position peaked at $420K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.